Leveraging artificial intelligence, computational biology, and advanced biotechnology to accelerate the discovery and development of next-generation therapeutic antibodies for precision medicine. This research integrates machine learning, bioinformatics, molecular modeling, and systems biology to identify novel disease targets, predict molecular interactions, engineer high-affinity monoclonal and bispecific antibodies, and optimize antibody-drug conjugates (ADCs). The goal is to improve therapeutic efficacy, enhance targeted delivery, and reduce the time and cost of translational research for cancer, inflammatory disorders, neurodegenerative conditions, and age-related diseases.
Investigating the role of chronic inflammation in neurodegenerative and age-related neurological diseases. Research focuses on microglial activation, cytokine signaling, blood-brain barrier dysfunction, and molecular pathways that contribute to conditions such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and cognitive decline associated with aging.
Investigating the cellular and molecular mechanisms that drive tissue repair, regeneration, and functional recovery in aging and disease. Research focuses on stem cell biology, tissue engineering, cellular reprogramming, regenerative signaling pathways, and biomolecular therapies to restore damaged tissues and enhance organ function. This work aims to develop innovative regenerative strategies for neurodegenerative disorders, cardiovascular disease, immune dysfunction, and age-related tissue degeneration.